Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Indian J Med Microbiol ; 2011 Jan-Mar; 29(1): 33-36
Article Dans Anglais | IMSEAR | ID: sea-143772

Résumé

Objectives: The aim of this investigation was to simultaneously detect and differentiate Mycoplasma genitalium and Ureaplasma urealyticum in female patients suffering from genital complications by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP). Materials and Methods : Genital swabs were taken from 210 patients. They were transported to the laboratory in phosphate-buffered saline. For PCR, samples were analysed with genus-specific MyUu-R and MyUu-F primers. This primer set, which was originally designed in our laboratory, amplified a 465 bp fragment (M. genitalium) and a 559 bp fragment (U. urealyticum). Samples containing a band of the expected sizes for the Mycoplasma strains were subjected to digestion with a restriction endonuclease enzyme of TaqI and Cac8I. Results: Of the 210 samples, a total of 100 (47.6%) samples were found to be positive for Mycoplasmas (seven M. genitalium isolates, 3.3%; and 89 U. urealyticum isolates, 42.4%), and coinfections with both species were detected in four samples (1.9%). The PCR-RFLP results showed that M. genitalium and U. urealyticum are different by enzyme patterns. Conclusion: PCR-RFLP offers a rapid and easily applicable protocol to simultaneous detection and differentiation of M. genitalium and U. urealyticum from clinical samples when specific primers and restriction enzymes are used.


Sujets)
Adulte , Sujet âgé , Techniques bactériologiques/méthodes , Diagnostic différentiel , Femelle , Système génital de la femme/microbiologie , Humains , Adulte d'âge moyen , Infections à Mycoplasma/diagnostic , Infections à Mycoplasma/microbiologie , Mycoplasma genitalium/classification , Mycoplasma genitalium/génétique , Mycoplasma genitalium/isolement et purification , Réaction de polymérisation en chaîne/méthodes , Polymorphisme de restriction , Grossesse , Complications infectieuses de la grossesse/diagnostic , Complications infectieuses de la grossesse/microbiologie , Facteurs temps , Infections à Ureaplasma/diagnostic , Infections à Ureaplasma/microbiologie , Ureaplasma urealyticum/classification , Ureaplasma urealyticum/génétique , Ureaplasma urealyticum/isolement et purification
2.
Indian J Med Microbiol ; 2009 Jan-Mar; 27(1): 30-4
Article Dans Anglais | IMSEAR | ID: sea-53954

Résumé

PURPOSE: Helicobacter pylori is the etiological agent in duodenal and peptic ulcers. The growing problem of antibiotic resistance by the organism demands the search for novel compounds, especially from natural sources. This study was conducted to evaluate the effect of Camellia sinensis extracts on the urease enzyme that is a major colonization factor for H. pylori. METHODS: Minimum inhibitory concentrations of nonfermented and semifermented C. sinensis methanol: water extracts were assessed by broth dilution method. Examination of the urease function was performed by Mc Laren method, and urease production was detected on 12% SDS polyacrylamide gel electrophoresis from whole cell and membrane bound proteins. RESULTS: Both extracts had inhibitory effects against H. pylori and urease production. At a concentration of 2.5 mg/ml of nonfermented extract and 3.5 mg/ml of semifermented extract the production of Ure A and Ure B subunits of the urease enzyme were inhibited completely. A concentration of 4 mg/ml of nonfermented and 5.5 mg/ml of semifermented extract were bactericidal for H. pylori. CONCLUSIONS: C. sinensis extracts, especially the nonfermented, could reduce H. pylori population and inhibit urease production at lower concentrations. The superior effect of nonfermented extract is due to its rich polyphenolic compounds and catechin contents.


Sujets)
Antibactériens/pharmacologie , Camellia sinensis/composition chimique , Antienzymes/pharmacologie , Helicobacter pylori/effets des médicaments et des substances chimiques , Tests de sensibilité microbienne , Viabilité microbienne , Extraits de plantes/pharmacologie , Urease/antagonistes et inhibiteurs
SÉLECTION CITATIONS
Détails de la recherche